Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Tumori|August 19, 2004
Extremely delayed cerebral metastasis from renal carcinoma: report of four cases and critical analysis of the literatureMarco Cimatti, Maurizio Salvati, Emanuela Caroli, et al.
Tumori|May 27, 2006
Treatment of glioblastoma multiforme in elderly patients. Clinico-therapeutic remarks in 22 patients older than 80 yearsManolo Piccirilli, Simona Bistazzoni, Franco Maria Gagliardi, et al.
Nursing in Critical Care|July 8, 2020
Prevalence and risk factors of delirium in the intensive care unit: An observational studyFrancesco Gravante, Diana Giannarelli, Antonello Pucci, et al.
Professioni Infermieristiche|October 3, 2020
[Emergency nurses and workplace violence: a cross-sectional study in Campania, South Italy]Francesco Gravante, Andrea Lombardi, Luciano Cecere, et al.
Biomedicines|August 29, 2024
BP1003 Decreases STAT3 Expression and Its Pro-Tumorigenic Functions in Solid Tumors and the Tumor MicroenvironmentMaria Gagliardi, Rhonda Kean, Bingbing Dai, et al.
Cancer Cell International|January 9, 2004
Inhibition of cell growth by EGR-1 in human primary cultures from malignant gliomaAntonella Calogero, Vincenza Lombari, Giorgia De Gregorio, et al.
Plos One|May 17, 2018
Clinically relevant inflammatory breast cancer patient-derived xenograft-derived ex vivo model for evaluation of tumor-specific therapiesBedrich L Eckhardt, Maria Gagliardi, LaKesla Iles, et al.
Scientific Reports|May 24, 2020
Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancerMaria Gagliardi, Mary Kathryn Pitner, Jihyun Park, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 12, 2010
The vascular targeting agent combretastatin-A4 and a novel cis-Restricted {beta}-Lactam Analogue, CA-432, induce apoptosis in human chronic myeloid leukemia cells and ex vivo patient samples including those displaying multidrug resistanceLisa M Greene, Seema M Nathwani, Sandra A Bright, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2016
Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in NeuroblastomaLori S Hart, JulieAnn Rader, Pichai Raman, et al.
Pageof 3